Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIENCY (Details 2)

v2.4.0.6
STOCKHOLDERS' DEFICIENCY (Details 2) (USD $)
3 Months Ended
Mar. 31, 2013
Dec. 31, 2012
Number of Shares, Outstanding at the beginning of the period 5,939,594 546,746
Number of Shares, Granted 3,810,000 5,395,000
Number of Shares, Exercised 0 0
Number of Shares, Forfeited 0 (2,152)
Number of Shares, Outstanding at the end of the period 9,749,594 5,939,594
Weighted Average Exercise Price, Outstanding at the beginning of the period $ 1.61 $ 17.08
Weighted Average Exercise Price, Granted $ 0.06 $ 0.04718
Weighted Average Exercise Price, Exercised $ 0 $ 0
Weighted Average Exercise Price, Forfeited $ 0 $ 14.1
Weighted Average Exercise Price, Outstanding at the end of the period $ 9.54 $ 1.61